Eagle Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-62,866
Closed -$1.64M 587
2020
Q1
$1.64M Buy
62,866
+4,966
+9% +$152K 0.01% 483
2019
Q4
$2.01M Buy
+57,900
New +$1.92M 0.01% 509

Other funds holding HCAT

Eagle Asset Management's HCAT Position: Q2 2020 in Review

Eagle Asset Management sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 62,866 shares — an estimated $1.64M sold.

Eagle Asset Management first reported a position in HCAT in Q4 2019 and held it in 2 quarters. The position peaked at $2.01M in Q4 2019. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • Eagle Asset Management reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • Eagle Asset Management sold 62,866 Health Catalyst shares in Q2 2020, an estimated $1.64M.
  • Eagle Asset Management first reported a position in Health Catalyst in Q4 2019 and held it in 2 quarters.
  • Eagle Asset Management's Health Catalyst position peaked at $2.01M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on Eagle Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.